Senate Targets Pharmacy Middlemen Amid Drug Price Deal Talks (1)

The Senate Finance Committee on Wednesday advanced a series of bipartisan proposals to tackle some of the problems with the entities that manage prescription drug coverage, as lawmakers face an unclear path forward on passing a larger drug pricing package.

The committee voted overwhelmingly, 26-1, in favor of moving to the Senate floor bills that would increase transparency over pharmacy benefit managers and prohibit certain pricing practices and fee collections. The single “no” vote came from Sen. Ron Johnson (R-Wis.).

PBMs have increasingly come under the microscope of multiple committees in both the House and Senate as the Federal Trade ...